Stockscreener 앱 받기
67.27
0.58%
-0.39
시간 외 거래:
66.50
-0.77
-1.14%
전일 마감가:
$67.66
열려 있는:
$67.98
하루 거래량:
3.74M
Relative Volume:
0.75
시가총액:
$25.89B
수익:
$4.66B
순이익/손실:
$836.30M
주가수익비율:
32.14
EPS:
2.093
순현금흐름:
$1.08B
1주 성능:
+3.08%
1개월 성능:
-6.92%
6개월 성능:
-0.27%
1년 성능:
-8.33%
1일 변동 폭
$67.10
$68.76
1주일 범위
$63.82
$68.76
52주 변동 폭
$54.11
$89.98
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
67.27 | 26.04B | 4.66B | 836.30M | 1.08B | 2.093 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Insider Selling: DexCom (NASDAQ:DXCM) EVP Sells 1,700 Shares of Stock - MarketBeat
Dexcom (DXCM) legal chief sells 1,700 shares in 10b5-1 trade - Stock Titan
Mizuho Markets Cayman LP Acquires 53,093 Shares of DexCom, Inc. $DXCM - MarketBeat
DXCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CIBC Private Wealth Group LLC Acquires 2,294,709 Shares of DexCom, Inc. $DXCM - MarketBeat
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
Block Trades: Will DexCom Inc outperform the market in YEAR2026 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal - MSN
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom, Inc. $DXCM Shares Purchased by Mizuho Markets Cayman LP - MarketBeat
Bank of Nova Scotia Trims Stake in DexCom - National Today
DexCom, Inc. $DXCM Shares Sold by Bank of Nova Scotia - MarketBeat
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know - Yahoo Finance
Here's why you should hold DexCom stock in your portfolio for now - MSN
[144] DEXCOM INC SEC Filing - Stock Titan
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - The Globe and Mail
Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? - Yahoo Finance
Iron Triangle Partners LP Purchases New Shares in DexCom, Inc. $DXCM - MarketBeat
Holocene Advisors Invests $163.96M in DexCom - National Today
Holocene Advisors LP Makes New $163.96 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. - National Today
DexCom, Inc. (DXCM) Showcases Next-Gen CGM Features at EASD 2025 - MSN
Cinctive Capital Management LP Takes $4.45 Million Position in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. $DXCM - MarketBeat
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment - The Motley Fool
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Aristotle Atlantic Partners LLC Makes New $13.01 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Is DexCom (DXCM) Fairly Priced After Recent Share Price Pullback? - simplywall.st
Prosight Management LP Boosts DexCom Stake by 178.9% - National Today
Prosight Management LP Acquires 125,217 Shares of DexCom, Inc. $DXCM - MarketBeat
Thematics Asset Management Has $24.38 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
Ossiam Has $18.15 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Wealth Advisors of Tampa Bay LLC Has $660,000 Holdings in DexCom, Inc. $DXCM - MarketBeat
Sirios Capital Management Boosts DexCom Stake by 75% - National Today
Sirios Capital Management L P Acquires 145,682 Shares of DexCom, Inc. $DXCM - MarketBeat
Assessing DexCom (DXCM) Valuation As Conference Highlights Growth In Glucose Monitoring Technology - simplywall.st
Devon Energy Corp Stock (ISIN: US2521311074) Gains Momentum Amid Oil Price Recovery - AD HOC NEWS
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
Meridiem Capital Partners LP Grows Stake in DexCom, Inc. $DXCM - MarketBeat
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Legal & General Group Plc Increases Stock Position in DexCom, Inc. $DXCM - MarketBeat
DXCM Stock Price, Quote & Chart | DEXCOM INC (NASDAQ:DXCM) - ChartMill
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
Swiss National Bank Trims Stake in DexCom by 4.8% - National Today
Swiss National Bank Sells 56,600 Shares of DexCom, Inc. $DXCM - MarketBeat
Mackenzie Financial Corp Raises Position in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Q3 2025 Earnings Call Transcript - MSN
Capital Research Global Investors Trims Holdings in DexCom, Inc. - National Today
Capital Research Global Investors Cuts Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Analysts Set DexCom, Inc. (NASDAQ:DXCM) PT at $85.18 - National Today
Is DexCom (DXCM) Quietly Reframing Its Innovation Moat With New Boardroom Tech Expertise? - simplywall.st
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.86%
0.79%
자본화:
|
볼륨(24시간):